Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$429,747,269
-$19,373,060 QoQ
Shares Held
1,707,786
-17.3% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#90
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. ABBV ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
|
3,938,865 | $94,847,869 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,747,269 | 1,707,786 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $449,120,329 | 2,065,016 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $474,382,255 | 2,076,162 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $518,208,979 | 2,238,097 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $433,924,059 | 2,337,701 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $523,744,686 | 2,499,736 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $433,108,032 | 2,437,299 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $459,783,402 | 2,328,253 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $395,758,901 | 2,307,363 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $378,659,832 | 2,079,406 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $281,867,184 | 1,818,850 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $241,916,777 | 1,622,949 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $220,415,315 | 1,635,978 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $275,871,223 | 1,731,011 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $298,516,457 | 1,847,141 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $257,991,748 | 1,922,299 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $300,224,691 | 1,960,203 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $312,782,491 | 1,929,446 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $259,907,611 | 1,919,554 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $266,161,350 | 2,467,427 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $291,591,505 | 2,588,703 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $268,186,583 | 2,478,161 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $242,295,294 | 2,261,272 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $88,863,120 | 1,014,535 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $27,975,507 | 284,941 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $21,350,342 | 280,225 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||